Goldman Sachs Group Inc Ikena Oncology, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 76,464 shares of IKNA stock, worth $107,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,464
Previous 76,464 -0.0%
Holding current value
$107,049
Previous $97,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$1.28 - $1.69 $37,592 - $49,633
29,369 Added 62.36%
76,464 $97,000
Q4 2024

Feb 11, 2025
SELL
$1.53 - $1.76 $17,637 - $20,289
-11,528 Reduced 19.66%
47,095 $77,000
Q3 2024

Nov 14, 2024
SELL
$1.6 - $1.85 $344,337 - $398,140
-215,211 Reduced 78.59%
58,623 $101,000
Q2 2024

Aug 13, 2024
BUY
$1.24 - $1.82 $249,533 - $366,251
201,237 Added 277.2%
273,834 $451,000
Q1 2024

May 15, 2024
BUY
$1.27 - $2.0 $62,232 - $98,004
49,002 Added 207.68%
72,597 $103,000
Q4 2023

Feb 13, 2024
BUY
$1.33 - $4.4 $2,933 - $9,706
2,206 Added 10.31%
23,595 $46,000
Q3 2023

May 14, 2024
SELL
$4.09 - $6.43 $9,022 - $14,184
-2,206 Reduced 9.35%
21,389 $92,000
Q3 2023

Nov 14, 2023
BUY
$4.09 - $6.43 $14,883 - $23,398
3,639 Added 20.5%
21,389 $92,000
Q2 2023

May 14, 2024
SELL
$3.5 - $7.31 $61,047 - $127,501
-17,442 Reduced 49.56%
17,750 $116,000
Q2 2023

Aug 14, 2023
SELL
$3.5 - $7.31 $61,047 - $127,501
-17,442 Reduced 49.56%
17,750 $116,000
Q1 2023

May 14, 2024
BUY
$2.62 - $4.97 $59,641 - $113,137
22,764 Added 183.17%
35,192 $121,000
Q1 2023

May 11, 2023
BUY
$2.62 - $4.97 $92,203 - $174,904
35,192 New
35,192 $121,000
Q3 2022

May 14, 2024
SELL
$3.46 - $6.0 $38,551 - $66,852
-11,142 Reduced 47.27%
12,428 $44,000
Q3 2022

Nov 10, 2022
SELL
$3.46 - $6.0 $38,551 - $66,852
-11,142 Reduced 47.27%
12,428 $0
Q2 2022

May 14, 2024
SELL
$3.23 - $7.4 $80 - $185
-25 Reduced 0.11%
23,570 $105,000
Q2 2022

Aug 15, 2022
SELL
$3.23 - $7.4 $8,233 - $18,862
-2,549 Reduced 9.76%
23,570 $105,000
Q1 2022

May 16, 2022
BUY
$5.61 - $13.85 $74,360 - $183,581
13,255 Added 103.04%
26,119 $160,000
Q4 2021

Feb 14, 2022
BUY
$10.52 - $16.96 $135,329 - $218,173
12,864 New
12,864 $161,000

Others Institutions Holding IKNA

# of Institutions
48
Shares Held
33.8M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $50.8M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email